Advertisement

How Can Duchenne Muscular Dystrophy be Treated?

An overview of the treatments for this common form of muscular dystrophy, including exon-skipping therapy.

Physical therapy is a standard part of treatment for Duchenne muscular dystrophy and can help maintain muscle strength and avoid contractures.

“What are the treatment options?” is one of the first questions a parent or caregiver will ask when a child is diagnosed with a form of muscular dystrophy.

Duchenne muscular dystrophy (DMD) is a genetic disorder that causes the loss of muscle strength and muscle mass. Symptoms appear before the age of six, and can include problems with motor skills, frequent falls, difficulty climbing stairs, or other signs of muscle weakness. Learning difficulties are also common. As DMD progresses, symptoms become more severe, leading to disability, cardiac problems, and other complications.

There is no cure for DMD, and treatment focuses on slowing the progression of the disease, improving quality of life, and controlling specific symptoms and complications that occur as a result of DMD.

Standard therapies

Corticosteroid medications, physical therapy, and exercise will likely be a part of a treatment plan for DMD.

  • Corticosteroids. Also called glucocorticoids or simply “steroids,” corticosteroids are anti-inflammatory medicines that are used to treat a wide variety of diseases. For people with DMD, certain corticosteroids can help slow the progression of muscle loss and help maintain muscle strength.
  • Physical therapy. A person with DMD should work with a physical therapist. Physical therapy can help maintain muscle strength and avoid contractures—which occur when a muscle, tendon, or ligament becomes permanently fixed and shortened, restricting normal movement and function. Physical therapy also includes the use of orthopedic braces and assistive devices.
  • Exercise. In addition to physical therapy, exercise and staying active is important. Bed rest and inactivity can make symptoms worse. Exercise and activity can help maintain strength and muscle mass. Gentle exercise is recommended—and a healthcare team can offer guidelines on what activities are safe.

Addressing specific symptoms

DMD is a progressive disease that gets worse over time, and a person with DMD will need to be monitored for changes and progression. Because DMD progresses differently for different people, a treatment plan will also be individualized to meet a person’s needs. A treatment plan may include:

  • Medications for heart problems, such as ACE inhibitors and/or beta blockers. There is also research that supports the idea that these medications can be given to prevent the onset of heart problems.
  • Respiratory therapy, speech therapy, and therapy to address difficulties with chewing and swallowing.
  • Counseling on diet and nutrition to help prevent malnutrition and obesity
  • Surgery to address contractures or scoliosis (curvature of the spine caused by weakened muscles)
  • Working with mental health professionals and/or social workers

Exon-skipping drugs

Duchenne muscular dystrophy is caused by mutations to the DMD gene. This gene contains instructions for making a protein called dystrophin. Muscles depend on this protein for repair. Mutations to this gene cause the body to produce dystrophin that does not work—and as a result, muscle tissues are easily damaged and cannot repair, and are gradually replaced with scar tissue and fat tissue.

The dystrophin gene includes 79 smaller components called exons. When a person has Duchenne muscular dystrophy, certain exons have mutations and others are normal. Genetic testing can determine which exons are affected.

Exon-skipping therapies use drugs that help cells skip over the mutated exons as they synthesize the dystrophin protein. This results in a dystrophin protein that functions better (though not perfectly). The goal of this therapy is to lessen the severity of Duchenne muscular dystrophy. (Keep in mind that this is a simplified explanation of a complex process.)

Several exon-skipping drugs are available, though they can only be used to treat cases of DMD that involve mutations to specific exons. More therapies are under development.

Clinical trials and investigational therapies

Participating in a clinical trial may be a way to access therapies for DMD that are under development and otherwise not yet available. These can include other exon-skipping therapies as well as gene therapies. If clinical trials are something you are interested in, talk to your child’s healthcare team, who will be able to explain how clinical trials work, what to expect, and next steps.

Article sources open article sources

Mount Sinai. Becker muscular dystrophy.
MedlinePlus. Duchenne muscular dystrophy.
Vijay Venugopal and Steven Pavlakis. Duchenne Muscular Dystrophy. StatPearls. July 11, 2022.
Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are the types and symptoms of muscular dystrophy (MD)?
Parent Project Muscular Dystrophy. Drug Development Pipeline.
Raphaal Porcher, Isabelle Desguerre, et al. Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data. European Heart Journal, 2021. Vol. 40, No. 20.
Stanford Medicine. Duchenne Muscular Dystrophy Treatment.
National Organization for Rare Disorders. Duchenne Muscular Dystrophy.
MedlinePlus. DMD gene.
Yacine Kharraz, Joana Guerra, et al. Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy. BioMed Research International. Vol. 2014.
Parent Project Muscular Dystrophy. Types of Mutations.
Muscular Dystrophy UK. What is exon skipping and how does it work?
Marisa Wexler. Exon Skipping for Duchenne Muscular Dystrophy. Muscular Dystrophy News Today. Feb. 14, 2022.
Shin’ichi Takeda, Paula R. Clemens, and Eric P. Hoffman. Exon-Skipping in Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases, 2021. Vol. 8, Suppl. 2.
Masafumi Matsuo. Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy. JMA Journal, 2021. Vol. 4, No. 3.
Children's Hospital of Philadelphia. Gene Therapy for Duchenne Muscular Dystrophy.

Featured Content

article

Questions About Duchenne Muscular Dystrophy Clinical Trials

What to ask your child’s healthcare providers about new treatments and clinical trials for Duchenne muscular dystrophy.
article

Duchenne Muscular Dystrophy and Caregiver Mental Health

If you are caring for a child with Duchenne muscular dystrophy, it’s important to care for yourself.
article

Early Signs and Symptoms of Duchenne Muscular Dystrophy

What parents need to know about the most common form of muscular dystrophy in children.
article

What Healthcare Providers Treat Duchenne Muscular Dystrophy?

A who’s who of the different members of the interdisciplinary team that treats Duchenne muscular dystrophy (DMD).
article

Understanding the Progression of Duchenne Muscular Dystrophy

How the symptoms of Duchenne muscular dystrophy (DMD) change as a person grows from childhood into young adulthood.